Gefitinib Long-term Survivor Study

Clinical trial NCT02932345 · TERMINATED

Trial details

NCT number: NCT02932345
Sponsor: AstraZeneca
Status: TERMINATED
Study type: OBSERVATIONAL

EGFR Mutation Positive Advanced Non-small-cell Lung Cancer

Start date: 2016-10-31
Primary completion: 2017-07-04
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.